1
Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
Condition(s):Primary Systemic Amyloidosis; Light Chain Deposition DiseaseLast Updated:September 13, 2022Active, not recruiting
Light Chain Deposition Disease: 21 Clinical Trials, Page 1 of 3
Hide Studies Not Open or Pending
2
First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD
Condition(s):Light Chain Deposition Disease; Primary Systemic AmyloidosisLast Updated:May 9, 2023Terminated
3
Detecting Early Myocardial Infiltration w/Amyloid & Light Chain Deposition Disease in Multiple Myeloma Subjects
Condition(s):Multiple MyelomaLast Updated:May 31, 2017Terminated
4
HD Melphalan and SCT in Patients With IGDD or LCDD
Condition(s):Multiple MyelomaLast Updated:April 28, 2017Terminated
5
Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
Condition(s):Light Chain Deposition Disease; Primary Systemic AmyloidosisLast Updated:February 1, 2022Completed
6
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Condition(s):Light Chain Deposition Disease; Smoldering Multiple MyelomaLast Updated:September 13, 2023Active, not recruiting
7
Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition(s):Light Chain Deposition Disease; Refractory Plasma Cell MyelomaLast Updated:April 15, 2015Completed
8
Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis
Condition(s):Light Chain Deposition Disease (LCDD or MIDD); Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD); Monoclonal Immunoglobulin Deposition Disease (MIDD); AmyloidosisLast Updated:April 7, 2020Completed
9
Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE)
Condition(s):AL Amyloidosis; Light Chain (AL) Amyloidosis; Systemic Light Chain DiseaseLast Updated:June 2, 2023Not yet recruiting
10
S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis
Condition(s):Multiple MyelomaLast Updated:March 6, 2015Completed